About this trial
With the title of "Long-Term Outcomes of endoscopic-assisted vs conventional breast-conserving surgery in breast cancer patients after neoadjuvant therapy: a randomized, multicenter, open label, non-inferiority trial", this study targets breast cancer patients after neoadjuvant therapy. A total of 804 eligible patients, after screening with inclusion and exclusion criteria, will be randomly assigned to Endoscopic-assisted breast conserving surgery(E-BCS) or conventional breast conserving surgery (C-BCS) group at a 1:1 ratio using stratified block randomization method, stratified by centers and molecular subtype. The co-primary endpoints are 5-year disease-free survival (5y-DFS) and Breast-Q score at 6 months after surgery. The secondary endpoints are cosmetic outcomes including surgeons' satisfaction with breast and patients' satisfaction with scar, survival outcomes including 5-year overall survival (5y-OS) and 5-year local-recurrence rate (5y-LRR), surgical outcomes including operative time, intraoperative blood loss, incision length and postoperative complications rate. This study aims to confirm the long-term safety and aesthetic outcome of endoscopic-assisted surgery in breast cancer patients after neoadjuvant treatment by comparing it with conventional open breast conserving surgery, and provide clinical evidence for the popularized application of endoscopic breast surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ranging from 18 to 75 years
Pathologically confirmed invasive breast cancer
Receiving preoperative chemotherapy (Each molecular subtype corresponds to unanimous regimen)
cT1-3N0-3M0
Disqualifiers
Diffusely disseminated malignant calcification foci
Not applicable for BCS after neoadjuvant therapy
Pregnancy or breastfeeding
Additional malignancy
Trial design
Parallel
Treatments tested in this trial
Surgery
Procedure/Surgerycomparison of 2 surgical procedures
Treatment groups
Trial outcomes
Primary outcomes
5-year disease free survival
The proportion of patients remaining after excluding patients with disease recurrence, metastasis or death from the time of surgery to 5-year follow-up
Patients' satisfaction with breast
The score of Breast-Q scale "Satisfaction with breasts" table 6 months after surgery
Secondary outcomes
Surgeons' satisfaction with breast
Surgeons evaluate the cosmetic outcome of breast based on the photos before surgery and after surgery. Four ranks: Excellent (9-10 points), Good (7-8 points), Fair (5-6 points) and Poor (0-4 points) are categorized on a basis of average total score from Ueda scale
Patients satisfaction with scar
Scar-Q scale including 3 tables about the surgical scar: appearance, symptom, psychosocial impact with total score of 100 will be used for evaluating patients satisfaction with scar
5-year overall survival
The proportion of patients remaining after excluding patients who died from any cause at 5-year follow-up
5-year local-regional recurrence rate
The proportion of patients with a lump found on breast, axilla, chest wall, skin or scars of surgery ipsilateral to the surgical side through physical examination or imaging, confirmed as the same pathological type as the primary tumor according to biopsy at 5-year follow up
Sponsors and contacts
Click on the lead sponsor to view all of their trials.